$15.19 0.53 (+3.62%)
2/13/2012 10:13 AM

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Featured Broker Partners


Advertisement